SOURCE: Medivation

Medivation

January 04, 2016 16:10 ET

Medivation to Present at J.P. Morgan Healthcare Conference

SAN FRANCISCO, CA--(Marketwired - Jan 4, 2016) - Medivation, Inc. (NASDAQ: MDVN) today announced that
David Hung, M.D., founder, president and chief executive officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2016, at 3:00pm PT at the Westin St. Francis Hotel in San Francisco, CA.

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at http://www.medivation.com.

Contact Information

  • Contacts:
    Anne Bowdidge
    Sr. Director, Investor Relations
    (650) 218-6900